T-cell immunotherapy is a rapidly growing personalized treatment, which expands unmodified cellular products ex vivo, for re-infusion into patients. This webinar, presented by Dr Christopher Lazarski of Childrens’ National Medical Center, will discuss the promise and pitfalls associated with developing individualized antigen specific T-cell therapy products for clinical use.
Watch the full webinar: [ Ссылка ]
0:11 hematopoietic stem cell transplant is used currently that can be used to treat patients with primary immunodeficiencies primary immunodeficiencies arise from genetic defects within the adaptive or innate immune cell compartment of X-linked SCID and RAG deficiencies are two well-known genetic defects stem cell transplant is able to restore function of the patient's immune system after hitting grafts, however, as shown here patients are susceptible to opportunistic infections before the transplant can fully aggress and there is this during this lag phase is when cell products that are manufactured in the GMP would provide the most benefit
Follow us on LinkedIn: [ Ссылка ]
Do not forget to subscribe to have better access to our videos!
#flowcytometry #cancerresearch #assay
